The finding by ourselves and others16 that a proportion of bladder cancers expresses both p53 and p21 suggests that p21 can be activated by a p53-independent pathway in these tumours, providing a rationale for some of them acquiring both p21 and p53 mutation. Here, CDKN1A is linked to urinary bladder carcinoma.